Silexion Therapeutics Corp (SLXNW) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	2.16M	3.38M	1.37M	2.21M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.14M	1.03M	1.38M	1.47M
Operating expense	3.29M	4.41M	2.75M	3.68M
Total operating expenses	3.29M	4.41M	2.75M	3.68M
Operating income	-3.29M	-4.41M	-2.75M	-3.68M
Other non operating income	23.00K	-35.00K	11.00K	129.00K
EBT including unusual items	-3.26M	-4.41M	-2.73M	-3.55M
EBT excluding unusual items	-3.26M	-4.41M	-2.73M	-3.55M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-3.26M	-4.41M	-2.73M	-3.55M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	39.00K	69.00K	32.00K	-
Interest expense	-	-	-	-
Net interest expenses	39.00K	69.00K	32.00K	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.29M	-4.40M	-2.75M	-3.68M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance